The estimated Net Worth of Partners L P/Ilbiotechnolog... is at least $882 Million dollars as of 27 April 2009. Partners Ilbiotechnolog owns over 2,970,000 units of Repligen stock worth over $853,476,074 and over the last 22 years Partners sold RGEN stock worth over $28,708,675.
Partners has made over 21 trades of the Repligen stock since 2003, according to the Form 4 filled with the SEC. Most recently Partners sold 2,970,000 units of RGEN stock worth $3,415,500 on 27 April 2009.
The largest trade Partners's ever made was selling 3,865,035 units of Repligen stock on 5 November 2003 worth over $19,325,175. On average, Partners trades about 214,049 units every 30 days since 2003. As of 27 April 2009 Partners still owns at least 5,951,716 units of Repligen stock.
You can see the complete history of Partners Ilbiotechnolog stock trades at the bottom of the page.
Partners's mailing address filed with the SEC is Michigan, USA.
Over the last 21 years, insiders at Repligen have traded over $118,224,292 worth of Repligen stock and bought 160,440 units worth $1,459,521 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Glenn P Muir, and Walter C Herlihy. On average, Repligen executives and independent directors trade stock every 33 days with the average trade being worth of $3,015,702. The most recent stock trade was executed by Ralf Kuriyel on 2 August 2024, trading 7,148 units of RGEN stock currently worth $1,139,034.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.
Repligen executives and other stock owners filed with the SEC include: